Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
absorb, accident, add, adeemed, adenoviral, adjudication, admission, advisor, Aeovian, affirmatively, affirmed, agonist, Allonge, Amgen, analyst, antibody, appraisal, ascribed, Asia, AstraZeneca, Bachelor, Bangalore, BDE, belief, beneficiary, BhB, bifurcated, Biocapital, biocryst, bound, boutique, breast, Brompton, Bryan, Buck, Buttner, Caldwell, Canaria, captioned, Cardiology, Cardium, categorize, CBE, cervical, CFO, chemotherapy, children, CIMR, CIRM, Cite, clarify, Clawback, CNS, Cognate, colorectal, compensatory, Complaint, conflict, conjugate, Connecticut, construed, contrary, conveyance, cooperating, counsel, County, covid, cyber, cybersecurity, Dartmouth, dealer, depository, designee, DGCL, disadvantage, Doctor, Duke, dulaglutide, EEA, effectuate, embedded, Entourage, epilepsy, Equiniti, Equinity, escalation, estate, etirinotecan, EvushieldTM, exacerbated, exhausted, exhaustive, exploring, expressly, extinguished, extinguishment, faculty, Fellow, FFV, Fiction, fifty, fill, filled, fluorescence, forma, formation, formatted, founder, fraction, fractional, Garnier, gas, Germain, GlaxoSmithKline, glossary, guaranty, Harvard, Hatch, hearing, honorary, house, Howard, HSV, HudsonAlpha, IIb, IM, implied, IMPORANT, impression, incident, inclined, inconvenient, inflation, inline, inquiry, interface, intermediary, intestacy, intolerable, Joan, Joinder, Journal, junior, JUV, Lancet, lawsuit, layer, Leahy, Leder, Ledger, Legacy, lent, lesser, Linkbase, Loyola, Lung, mail, mailing, Mailk, maker, Marshall, MBA, McGill, MD, MDV, Meger, MidCity, Milton, mining, Mintz, Mississippi, Moreadith, Mounjaro, Movantik, moved, nalexogol, Napa, Navasota, nearest, Nektar, Neulasta, neurocognitive, Neuroscience, Newcastle, ninety, nominee, nonrestricted, North, numerator, Ocriplasmin, oil, Oman, opposed, ovarian, overnight, Oxurion, Ozempic, Page, parity, parri, partnership, passu, Paul, PEG, pegol, PEGylated, pendency, peramivir, Philip, piggyback, pill, plaintiff, PlatformTM, prejudice, professor, properly, pure, purportedly, Queen, radiation, Ramsey, Randall, Rapivab, ratify, RCP, read, reclassify, reconsideration, recoup, referenced, refractory, Remy, Renondin, resolution, Respiratory, Richard, River, Roche, satisfactorily, Schema, School, scrip, Secretary, seed, Selah, semaglutide, Shearwater, sitting, Smith, sorting, Sovereign, spendable, startup, Steve, Steven, strictly, studio, subdivide, subsection, successor, superior, Sutter, Tacey, takeover, Taxonomy, tenure, theretofore, thoracic, tirzepatide, transferee, transferor, Trulicity, Tuck, unattractive, unduly, Universite, UniverXome, unsolicited, vacancy, vaccine, Vaxzevria, venture, venue, VIE, Viking, Viscogliosi, visiting, Wegovy, workforce, wrongdoing, XBRL, Zepbound
Removed:
abnormally, absenteeism, acting, actively, administer, advertisement, Africa, altered, amortize, Annalisa, arm, Asklepian, assay, ATM, Auditing, augment, averaged, baby, Baylor, bid, Biochemical, biocompatibility, biodegradability, biomaterial, Biophysical, Bioscience, bone, borrow, Bradsher, Broadwood, broke, Bureau, carryback, CCRM, CE, ceased, Centre, CEO, cloning, communicating, comparing, compatible, concentrating, concert, consisted, consolidating, consortium, constitutional, contour, convene, COO, criterion, crosslinking, database, declining, deconsolidated, deferment, delisted, denominated, deriving, detrimental, diacrylate, diagnostic, dichotomy, disclaimed, discontinued, distance, dogma, door, economy, elderly, employer, engraftment, entitle, entitling, Entrepreneurship, essential, evolution, evolving, Excellence, expended, facial, feet, finite, forecasted, forgiven, formulated, frame, France, fulfill, fulltime, gave, Gearhart, gel, gelatin, gelation, germ, Germany, Geron, GILTI, glycol, graft, harnessing, Hayflick, heparin, hyaluronan, hydrogel, identification, ill, immortalize, industrial, infected, inhibition, initiated, insolvent, Integration, intelligence, interdealer, Ireland, ISCT, isolation, Italy, John, judgement, lab, lacked, Lee, Leonard, LifeMap, lipoatrophy, Liverpool, living, LLP, localize, localized, locally, Luxembourg, Mark, marked, Martin, MBChB, measuring, mechanism, Menlo, merge, millennia, Monaco, mortal, mortality, MPhil, multicellular, Neal, network, noncash, nonregenerative, NSERC, NY, online, originally, OUM, overlap, oxygen, pandemic, parse, Paycheck, pecuniary, Pedersen, PEGDA, permeability, perpetuate, phenomenon, phenotype, pioneer, polyethylene, Polytechnic, PPP, precise, prepare, presidential, primitive, programmed, progressive, proliferate, promptly, publication, reach, recovery, refundable, registrable, relevance, relocated, remotely, Renevia, renowned, Rensselaer, repealing, repression, reset, resign, revolution, revolutionary, Rimon, robust, Roger, safely, sampling, Scholar, screening, sharp, shortening, showing, slowly, Society, South, Spain, stably, stroke, structural, suggest, supercentenarian, supplying, supporting, Supreme, surgically, Switzerland, synthetic, tangible, thiol, thiolated, Thomson, Transcriptase, uncover, underwriter, undischarged, unicellular, unilaterally, unique, unsolved, Utah, Virgin, Walmsley, water
Filing tables
Filing exhibits
SER similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-251988), Form S-8 (Nos. 333-229432, 333-261997, and 333-269588), and Form S-4 (No. 333-275536) of AgeX Therapeutics, Inc. of our report dated March 22, 2024, which includes an explanatory paragraph relating to AgeX Therapeutics, Inc.’s ability to continue as a going concern, relating to the consolidated financial statements of AgeX Therapeutics, Inc. as of and for the years ended December 31, 2023 and 2022, which appears in this Form 10-K.
/s/ WithumSmith+Brown, PC | |
San Francisco, California | |
March 22, 2024 |